The prognostic impact of occult nodal metastasis in early breast carcinoma

Breast Cancer Research and Treatment

Volumn 118, Issue 1, 2009, Pages 57-66

  Park, Daehoon ^a   Kåresen, Rolf ^b   Naume, Bjørn ^b   Synnestvedt, Marit ^b   Beraki, Elsa ^a   Sauer, Torill ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Axillary lymph node; Invasive breast cancer; Occult metastasis; Prognosis; Survival

Indexed keywords

CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; CELL ISOLATION; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BONE MARROW; BREAST NEOPLASMS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; METHOTREXATE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, HORMONE-DEPENDENT; NORWAY; PROGNOSIS; TAMOXIFEN;

EID: 70349914380     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0340-2     Document Type: Article

References (35)

1. M Lacroix 2006 Significance, detection and markers of disseminated breast cancer cells Endocr Relat Cancer 13 1033 1067 10.1677/ERC-06-0001 10.1677/ERC-06-0001 1:CAS:528:DC%2BD2sXisFaktrY%3D 17158753 (Pubitemid 46212562)
2. KK Swenson MJ Nissen C Ceronsky, et al. 2002 Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer Ann Surg Oncol 9 745 753 10.1007/BF02574496 12374657
3. DK Blanchard JH Donohue C Reynolds CS Grant 2003 Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer Arch Surg 138 482 488 10.1001/archsurg.138.5.482 10.1001/archsurg.138.5.482 12742949 (Pubitemid 36542459)
4. Greene FL, Page DL, Fleming ID et al (2002) American Joint Committee on cancer staging manual, 6th edn. Springer, New York
5. K Dowlatshahi M Fan HC Snider FA Habib 1997 Lymph node micrometastases from breast carcinoma: reviewing the dilemma Cancer 80 1188 1197 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO;2-H 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO;2-H 1:STN:280:DyaK2svmtFCrug%3D%3D 9317169 (Pubitemid 27407219)
6. D Hawes AM Neville RJ Cote 2001 Detection of occult metastasis in patients with breast cancer Semin Surg Oncol 20 312 318 10.1002/ssu.1049 10.1002/ssu.1049 1:STN:280:DC%2BD3Mnps1CntA%3D%3D 11747273 (Pubitemid 33044275)
7. A Chagpar LP Middleton AA Sahin, et al. 2005 Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry Cancer 103 1581 1586 10.1002/cncr.20934 10.1002/cncr.20934 15747375 (Pubitemid 40490018)
8. CE Cox JV Kiluk AI Riker, et al. 2008 Significance of sentinel lymph node micrometastases in human breast cancer J Am Coll Surg 206 261 268 10.1016/j.jamcollsurg.2007.08.024 10.1016/j.jamcollsurg.2007.08.024 18222378
9. MC Cummings MD Walsh BG Hohn, et al. 2002 Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis Am J Surg Pathol 26 1286 1295 10.1097/00000478-200210000-00005 10.1097/00000478- 200210000-00005 1:STN:280:DC%2BD38vpslGjtQ%3D%3D 12360043
10. GS Herbert VY Sohn TA Brown 2007 The impact of nodal isolated tumor cells on survival of breast cancer patients Am J Surg 193 571 574 10.1016/j.amjsurg.2007.01.007 10.1016/j.amjsurg.2007.01.007 17434357 (Pubitemid 46559901)
11. HJ Kahn WM Hanna JA Chapman, et al. 2006 Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system Breast J 12 294 301 10.1111/j.1075-122X.2006.00267.x 10.1111/j.1075-122X.2006.00267.x 16848838 (Pubitemid 43989974)
12. RR Millis R Springall AH Lee, et al. 2002 Occult axillary lymph node metastases are of no prognostic significance in breast cancer Br J Cancer 86 396 401 10.1038/sj.bjc.6600070 10.1038/sj.bjc.6600070 1:STN:280: DC%2BD387jvVyisQ%3D%3D 11875706 (Pubitemid 34185124)
13. B Susnik S Frkovic-Grazio M Bracko 2004 Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up Ann Surg Oncol 11 568 572 10.1245/ASO.2004.10.021 10.1245/ASO.2004.10.021 15150071 (Pubitemid 40486713)
14. LK Tan D Giri AJ Hummer, et al. 2008 Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up J Clin Oncol 26 1803 1809 10.1200/JCO.2007.12. 6425 10.1200/JCO.2007.12.6425 18332473
15. B Fisher M Bauer DL Wickerham, et al. 1983 Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update Cancer 52 1551 1557 10.1002/1097-0142(19831101)52:9<1551::AID- CNCR2820520902>3.0.CO;2-3 10.1002/1097-0142(19831101)52:9<1551::AID- CNCR2820520902>3.0.CO;2-3 1:STN:280:DyaL2c%2FgtFyhtQ%3D%3D 6352003
16. PP Rosen PE Saigo DW Braun Jr, et al. 1981 Predictors of recurrence in stage I (T1N0M0) breast carcinoma Ann Surg 193 15 25 10.1097/00000658-198101000- 00003 10.1097/00000658-198101000-00003 1:STN:280:DyaL3M7gvVCrtQ%3D%3D 7458446
17. S Braun BS Cevatli C Assemi, et al. 2001 Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy J Clin Oncol 19 1468 1475 1:STN:280:DC%2BD3M7osVGqsg%3D%3D 11230493
18. G Wiedswang AB Naess B Naume R Karesen 2001 Micrometastasis to axillary lymph nodes and bone marrow in breast cancer patients Breast 10 237 242 10.1054/brst.2000.0245 10.1054/brst.2000.0245 1:STN:280:DC%2BD2c%2FpsVWisw%3D%3D 14965591 (Pubitemid 32529952)
19. B Gerber A Krause H Muller, et al. 2001 Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors J Clin Oncol 19 960 971 1:STN:280:DC%2BD3M3gsFamug%3D%3D 11181658
20. B Naume E Borgen G Kvalheim, et al. 2001 Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics Clin Cancer Res 7 4122 4129 1:STN:280:DC%2BD38%2Fgt1Clsg%3D%3D 11751511
21. G Wiedswang E Borgen R Karesen, et al. 2003 Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer J Clin Oncol 21 3469 3478 10.1200/JCO.2003.02.009 10.1200/JCO.2003.02.009 1:STN:280:DC%2BD3svjtFyksQ%3D%3D 12972522 (Pubitemid 46594079)
22. Brystkreft. Diagnostikk og behandling. Norwegian Breast Cancer Group. 4th Edition 1994 and 5th Edition 1998 (in Norwegian)
23. PJ Hainsworth JJ Tjandra RG Stillwell, et al. 1993 Detection and significance of occult metastases in node-negative breast cancer Br J Surg 80 459 463 10.1002/bjs.1800800417 10.1002/bjs.1800800417 1:STN:280: DyaK3s3msFartg%3D%3D 8388305
24. M Trojani I de Mascarel F Bonichon, et al. 1987 Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance Br J Cancer 55 303 306 1:STN:280: DyaL2s7osFahtg%3D%3D 3552017 (Pubitemid 17036845)
25. International (Ludwig) Breast Cancer Study Group 1990 Prognostic importance of occult axillary lymph node micrometastases from breast cancers Lancet 335 1565 1568
26. I de Mascarel F Bonichon JM Coindre M Trojani 1992 Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up Br J Cancer 66 523 527 1520589
27. EV Madsen J van Dalen J van Gorp, et al. 2008 Strategies for optimizing pathologic staging of sentinel lymph nodes in breast cancer patients Virchows Arch 453 17 24 10.1007/s00428-008-0601-1 10.1007/s00428-008-0601-1 18563440
28. D Park R Karesen U Axcrona, et al. 2007 Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis APMIS 115 52 65 10.1111/j.1600-0463.2007.apm-524. x 10.1111/j.1600-0463.2007.apm-524.x 1:CAS:528:DC%2BD2sXis1OltL8%3D 17223851 (Pubitemid 46066574)
29. I Langer U Guller OR Koechli, et al. 2007 Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study Ann Surg Oncol 14 1896 1903 10.1245/s10434-006-9193-7 10.1245/s10434-006-9193-7 17356955 (Pubitemid 46870929)
30. BA Carter RA Jensen JF Simpson DL Page 2000 Benign transport of breast epithelium into axillary lymph nodes after biopsy Am J Clin Pathol 113 259 265 10.1309/7EF8-F1W7-YVNT-H8H5 10.1309/7EF8-F1W7-YVNT-H8H5 1:STN:280: DC%2BD3c7ivVSisQ%3D%3D 10664628
31. AM Naik J Fey M Gemignani, et al. 2004 The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures Ann Surg 240 462 468 10.1097/01.sla.0000137130.23530.19 10.1097/01.sla.0000137130.23530. 19 15319717 (Pubitemid 39121340)
32. B Fisher S Anderson J Bryant, et al. 2002 Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 1233 1241 10.1056/NEJMoa022152 10.1056/NEJMoa022152 12393820 (Pubitemid 35176242)
33. GP Kuijt LV van de Poll-Franse RM Roumen, et al. 2006 The significance of one positive axillary node Eur J Surg Oncol 32 139 142 10.1016/j.ejso.2005.11. 015 10.1016/j.ejso.2005.11.015 1:STN:280:DC%2BD287gtlCitQ%3D%3D 16412602 (Pubitemid 43257112)
34. G Viale E Maiorano G Pruneri, et al. 2005 Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy Ann Surg 241 319 325 10.1097/01.sla.0000150255.30665. 52 10.1097/01.sla.0000150255.30665.52 15650643
35. EJ Rutgers P Meijnen H Bonnefoi 2004 Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group Breast Cancer Res 6 165 169 10.1186/bcr906 10.1186/bcr906 15217489 (Pubitemid 39136485)